Kazakh Institute of Oncology and Radiology
Almaty, 050000, Kazakhstan
NCT Number: NCT06952361
This is a prospective, single-center observational study conducted at the Kazakh Institute of Oncology and Radiology. The study included 107 clinically stable adult patients with cancer who required red blood cell transfusion based on a restrictive hemoglobin threshold. The aim of the study was to evaluate alternative physiological indicators of transfusion need and effectiveness. Measurements included oxygen extraction ratio (O₂ER), central venous oxygen saturation (ScvO₂), partial pressure of oxygen in central venous blood (PvO₂), arterio-venous oxygen difference (A-VO₂diff), lactate, and veno-arterial carbon dioxide difference (ΔCO₂). These parameters were assessed before and one hour after transfusion. For data analysis, patients were stratified into two groups based on their baseline O₂ER (≤35.4% and >35.4%) to evaluate whether higher O₂ER is associated with more pronounced physiological response to transfusion.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Almaty, 050000, Kazakhstan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard red blood cell transfusion performed as part of routine clinical care. All participants received one or more units of RBCs based on a restrictive hemoglobin threshold. The transfusion protocol was not altered for the purpose of the study.
Time frame: Baseline and 1 hour post-transfusion
Difference in oxygen extraction ratio measured before and one hour after red blood cell transfusion
Time frame: Baseline and 1 hour post-transfusion
Difference in PvO₂ measured before and one hour after transfusion
Time frame: Baseline and 1 hour post-transfusion
Difference in ScvO₂ measured before and one hour after transfusion
Time frame: Baseline and 1 hour post-transfusion
Difference in serum lactate measured before and one hour after transfusion
Time frame: Baseline and 1 hour post-transfusion
Difference in arteriovenous oxygen difference measured before and one hour after transfusion
Time frame: Baseline and 1 hour post-transfusion
Difference in ΔCO₂ measured before and one hour after transfusion
Ardak Arynov
Other
Evaluation of Alternative Transfusion Triggers in Hemodynamically Stable, Non-Ventilated Cancer Patients: A Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03837171
Anemia, Cancer
Amiens, France
View Trial DetailsNCT04246021
Anemia, Cancer
View Trial DetailsNCT00153868
Anemia, Cancer
Lebanon, New Hampshire, United States
View Trial DetailsNCT04779840
Anemia, Cancer
Le Mans, France
View Trial Details